Marker Therapeutics Ownership | Who Owns Marker Therapeutics?
Marker Therapeutics Ownership Summary
Marker Therapeutics is owned by 0.79% institutional investors, 12.20% insiders, and 87.01% retail investors. Ar asset management is the largest institutional shareholder, holding 0.79% of MRKR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.72% of its assets in Marker Therapeutics shares.
MRKR Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Marker Therapeutics | 0.79% | 12.20% | 87.01% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Ar asset management | 70.70K | 0.79% | $384.00K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Ar asset management | 70.70K | 0.09% | $384.00K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ar asset management | 70.70K | 0.09% | - |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ar asset management | 70.70K | 0.09% | - |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 1 | - | 70,700 | - | - | 125.86% | - | - | - | - |
Mar 31, 2024 | 1 | - | 70,700 | - | - | 123.79% | - | - | - | - |
Dec 31, 2023 | 1 | - | 70,700 | - | - | 124.07% | - | -100.00% | - | - |
Sep 30, 2023 | 1 | - | 70,700 | 73.71% | - | 368.91% | 1 | - | - | - |
Jun 30, 2023 | 1 | -50.00% | 40,700 | -88.53% | - | 2.82% | - | -100.00% | - | -100.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 153.47K | 1.72% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 87.14K | 0.98% | - |
Fidelity Extended Market Index | 40.84K | 0.46% | 3.17K |
WEALTHGATE Biotech Aggressive Fund I | 25.44K | 0.29% | - |
iShares Micro-Cap ETF | 16.58K | 0.19% | - |
DFA US Small Cap I | 15.90K | 0.18% | - |
WEALTHGATE Biotech Fund Inst | 9.51K | 0.11% | - |
Fidelity Series Total Market Index | 9.02K | 0.10% | - |
Fidelity Total Market Index | 8.95K | 0.10% | - |
NT Ext Equity Mkt Idx Fd - NL | 5.80K | 0.07% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 16, 2021 | Eansor Norman David | - | Buy | $249.99K |
May 18, 2021 | Wasserman Frederick Gerald | - | Buy | $24.10K |
Mar 16, 2021 | Walker Paul Edward | - | Buy | $10.00M |
Mar 16, 2021 | Sonsini Peter W. | - | Buy | $10.00M |
Mar 16, 2021 | SANDELL SCOTT D | - | Buy | $10.00M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2023 Q2 | - | - |
2023 Q1 | - | - |
2022 Q2 | - | - |
2022 Q1 | - | - |
2021 Q4 | - | - |
MRKR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools